Arvinas, Inc. (ARVN)

  • BCG Recommendation

Balfour Capital Group Researched ARVINAS, INC. on February 1st, 2024.

Arvinas, Inc. is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.

Post Recommendation Price Trend Chart

Analysts Research

With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.

2023 Q3 Earning Report

A Q3 report evaluates company financials for investors

TGT Report

View

Morgan Stanley ON TGT

Morgan Stanley researches Industries, offers insights to clients

Morgan Stanley Notes

View

Thomson Reuters on TGT

Thomson Reuters delivers global financial, legal, and business information to professionals.

Thomson Reuters

View
Balfour Capital Group wants to clarify that our recommendation to Buy ARVINAS, INC. (ARVN) is based on thorough research conducted by our dedicated teams. We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance. However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.

*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
error: Content is protected !!